Vestcor Inc’s Insmed INSM Stock Holding History

Vestcor Inc’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$693K	Hold	4,238	–	–	0.02%	618
2025 Q4	$738K	Buy	+4,238	New	+$773K	0.02%	571
2023 Q1	–	Sell	-3,730	Closed	-$75K	–	1224
2022 Q4	$75K	Buy	+3,730	New	+$72.1K	﹤0.01%	1094
2022 Q2	–	Sell	-888	Closed	-$21K	–	1415
2022 Q1	$21K	Hold	888	–	–	﹤0.01%	1272
2021 Q4	$24K	Buy	+888	New	+$25.4K	﹤0.01%	1300

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vestcor Inc's INSM Position: Q1 2026 in Review

Vestcor Inc held its Insmed (INSM) position steady in Q1 2026 at 4,238 shares worth $693K. The position accounts for 0.02% of the portfolio, ranked #618.

Vestcor Inc first reported a position in INSM in Q4 2021 and has held it in 5 quarters since. The position peaked at $738K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Vestcor Inc held 4,238 shares of Insmed worth $693K as of Q1 2026.
Vestcor Inc left its Insmed share count unchanged in Q1 2026.
Insmed made up 0.02% of Vestcor Inc's portfolio in Q1 2026, its #618 holding.
Vestcor Inc first reported a position in Insmed in Q4 2021 and has held it in 5 quarters since.
Vestcor Inc's Insmed position peaked at $738K in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.